SCHEMBL30977183

SCHEMBL30977183

CCOC(=O)[C@H](CCC(=O)C1CC1)NC(=O)OC(C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
HTT P42858 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.47
ALDH1A1 P00352 4/20 0.45
MAPT P10636 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 1/20 0.42
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
HPGD P15428 1/20 0.42
ALOX12 P18054 1/20 0.42
KMT2A Q03164 4/20 0.42
POLB P06746 1/20 0.42
CTSK P43235 6/20 0.41
CTSS P25774 5/20 0.41
MEN1 O00255 1/20 0.40
TSHR P16473 1/20 0.40
HDAC4 P56524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30977182 1.00 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL22451614 0.95 CYP1A2 (0.52) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL8065326 0.92 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL13405298 0.92 CYP1A2 (0.49) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL28286746 0.86 ITGB3 (0.47) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL28286745 0.86 ITGB3 (0.47) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL31498517 0.85 CTSS (0.46) KMT2ACTSKCTSSTSHRHDAC4
SCHEMBL646731 0.83 CYP1A2 (0.59) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL24692237 0.82 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2
SCHEMBL2721300 0.82 CYP1A2 (0.68) CYP1A2CYP2C9CYP2C19HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4640684-A1 KRAS G12D INHIBITORS AND USES THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2025-10-29 EP disclosed
WO-2024131827-A1 KRAS G12D INHIBITORS AND USES THEREOF 上海和誉生物医药科技有限公司 2024-06-27 WO disclosed